Imagion Biosystems Limited has announced Appendix 3B, “New issue announcement, application for quotation of additional securities and agreement.”
Read Appendix 3B.
Positive independent review sets priority path to market for MagSense® Technology
Highlights Blinded review by panel of expert breast radiologists corroborates potential for MagSense® nanoparticle technology to detect tumour cells in lymph nodes by Magnetic Resonance